The Ritedose Corporation Recalls Formoterol Fumarate Inhalation Solution Over Impurities
The Ritedose Corporation is recalling 3,210 cartons of Formoterol Fumarate Inhalation Solution due to failed impurities specifications.
The Ritedose Corporation is recalling Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 and 60 individually wrapped vials. The prescription product was manufactured for and by Ritedose Pharmaceuticals, LLC.
The recall was issued because the medication failed impurities and degradation specifications. This issue indicates that the product may contain unacceptable levels of impurities or degraded active ingredients.
The affected medication was distributed nationwide within the United States, totaling 3,210 cartons. The U.S. Food and Drug Administration is overseeing this Class II recall.
What to do
- Stop using the recalled inhalation solution immediately.
- Consult your healthcare provider or doctor to obtain a replacement prescription or alternative treatment.
- Contact The Ritedose Corporation or the FDA if you have questions or need additional information.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | D-0073-2027 |
| Date | 2026-11-04 |
| Company | The Ritedose Corporation, Columbia, SC |
| Severity | Class II |
| Quantity | 3210 Cartons |
| Where sold | Nationwide within the U.S |
| Lot codes / identifiers | Lot: 25BL0, Expires: 02/28/2027 |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.